Bracco
Bracco, founded in 1927, specializes in diagnostic imaging, particularly contrast imaging, and holds a robust portfolio including contrast agents, medical devices, and advanced imaging solutions.
Company History
Bracco was founded in 1927, establishing itself over the decades as a significant player in the field of Diagnostic Imaging. Throughout its history, the company has maintained a focus on contrast imaging, continually advancing its offerings to meet the changing needs of the healthcare sector.
Diagnostic Imaging Sector
Bracco is deeply engaged in the Diagnostic Imaging sector, with a primary focus on contrast imaging. The company's portfolio includes a wide range of contrast agents, medical devices, and advanced solutions designed to support healthcare professionals in accurate and effective diagnosis.
Research and Development
Bracco invests approximately 10% of its turnover in research and development, reflecting its strong commitment to innovation. The company holds over 2,500 active patents and operates 10 research centers globally, driving forward advancements in the Diagnostic Imaging field.
Sustainability Initiatives
Committed to sustainability, Bracco has set specific goals and publicly reports on its progress. The company has been recognized for its efforts with a Gold Medal from EcoVadis, underscoring its dedication to sustainable practices across its operations.
Educational and Collaborative Efforts
Bracco actively participates in global healthcare events and conferences and provides e-learning courses for healthcare professionals. Additionally, the company engages in partnerships with educational institutions and other entities to facilitate knowledge exchange and enhance the capabilities of healthcare providers.